• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4710973)   Today's Articles (5431)
Download
Rank Citation Analysis Article
Type
Number of Years Citation(s) in RCA
1
Iqbal S, Blenner M, Alexander-Bryant A, Larsen J. Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications. Biomacromolecules 2020;21:1327-1350. [DOI: 10.1021/acs.biomac.9b01754] [Citation(s) in RCA: 89] [Impact Index Per Article: 17.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
5 89
2
Caffery B, Lee JS, Alexander-Bryant AA. Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies. NANOMATERIALS (BASEL, SWITZERLAND) 2019;9:E105. [PMID: 30654536 PMCID: PMC6359729 DOI: 10.3390/nano9010105] [Citation(s) in RCA: 86] [Impact Index Per Article: 14.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/13/2018] [Revised: 12/21/2018] [Accepted: 01/03/2019] [Indexed: 12/14/2022]
Review 6 86
3
Alexander-Bryant AA, Vanden Berg-Foels WS, Wen X. Bioengineering strategies for designing targeted cancer therapies. Adv Cancer Res 2013;118:1-59. [PMID: 23768509 DOI: 10.1016/b978-0-12-407173-5.00002-9] [Citation(s) in RCA: 56] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Research Support, N.I.H., Extramural 12 56
4
Samec T, Boulos J, Gilmore S, Hazelton A, Alexander-Bryant A. Peptide-based delivery of therapeutics in cancer treatment. Mater Today Bio 2022;14:100248. [PMID: 35434595 PMCID: PMC9010702 DOI: 10.1016/j.mtbio.2022.100248] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Revised: 03/14/2022] [Accepted: 03/27/2022] [Indexed: 11/09/2022]  Open
Review 3 21
5
Alexander-Bryant AA, Zhang H, Attaway CC, Pugh W, Eggart L, Sansevere RM, Andino LM, Dinh L, Cantini LP, Jakymiw A. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncol 2017;72:123-131. [PMID: 28797448 DOI: 10.1016/j.oraloncology.2017.07.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2017] [Revised: 06/19/2017] [Accepted: 07/04/2017] [Indexed: 01/27/2023]
Journal Article 8 20
6
Alexander-Bryant AA, Dumitriu A, Attaway CC, Yu H, Jakymiw A. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. J Control Release 2015;218:72-81. [PMID: 26386438 DOI: 10.1016/j.jconrel.2015.09.026] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2015] [Revised: 08/28/2015] [Accepted: 09/14/2015] [Indexed: 11/18/2022]
Research Support, N.I.H., Extramural 10 13
7
Pitz ME, Nukovic AM, Elpers MA, Alexander-Bryant AA. Factors Affecting Secondary and Supramolecular Structures of Self-Assembling Peptide Nanocarriers. Macromol Biosci 2021;22:e2100347. [PMID: 34800001 DOI: 10.1002/mabi.202100347] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2021] [Revised: 10/19/2021] [Indexed: 01/12/2023]
Review 4 11
8
Miller EM, Samec TM, Alexander-Bryant AA. Nanoparticle delivery systems to combat drug resistance in ovarian cancer. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 2020;31:102309. [PMID: 32992019 DOI: 10.1016/j.nano.2020.102309] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Revised: 09/04/2020] [Accepted: 09/17/2020] [Indexed: 12/17/2022]
Research Support, U.S. Gov't, Non-P.H.S. 5 10
9
Attia MF, Montaser AS, Arifuzzaman M, Pitz M, Jlassi K, Alexander-Bryant A, Kelly SS, Alexis F, Whitehead DC. In Situ Photopolymerization of Acrylamide Hydrogel to Coat Cellulose Acetate Nanofibers for Drug Delivery System. Polymers (Basel) 2021;13:1863. [PMID: 34205186 PMCID: PMC8200032 DOI: 10.3390/polym13111863] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2021] [Revised: 05/31/2021] [Accepted: 05/31/2021] [Indexed: 01/17/2023]  Open
research-article 4 6
10
Mbiki S, McClendon J, Alexander-Bryant A, Gilmore J. Classifying changes in LN-18 glial cell morphology: a supervised machine learning approach to analyzing cell microscopy data via FIJI and WEKA. Med Biol Eng Comput 2020;58:1419-1430. [PMID: 32314170 DOI: 10.1007/s11517-020-02177-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2019] [Accepted: 04/01/2020] [Indexed: 11/29/2022]
Journal Article 5 2
11
Samec T, Alatise KL, Boulos J, Gilmore S, Hazelton A, Coffin C, Alexander-Bryant A. Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer. MOLECULAR THERAPY. NUCLEIC ACIDS 2022;30:95-111. [PMID: 36213692 PMCID: PMC9530961 DOI: 10.1016/j.omtn.2022.09.012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Accepted: 09/15/2022] [Indexed: 06/16/2023]
research-article 3 1
12
Gardner S, Alatise KL, Miller E, Grant E, Alexander-Bryant A. Abstract 306: Cationic cholesterol liposomes for combination therapy to treat drug-resistant ovarian cancer. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-306] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
4 1
13
Alatise KL, Gardner S, Alexander-Bryant A. Abstract 281: pH-sensitive liposome for siRNA delivery to treat drug-resistant ovarian cancer. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-281] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
4 1
14
Alexander-Bryant A, Dumitriu A, Attaway C, Yu H, Jakymiw A. Abstract LB-106: Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. Cancer Res 2015. [DOI: 10.1158/1538-7445.am2015-lb-106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
10
15
Boulos J, Alexander-Bryant A. Abstract 1310: Peptide delivery of siRNA in GBM. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-1310] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
4
16
Attia MF, Ogunnaike EA, Pitz M, Elbaz NM, Panda DK, Alexander-Bryant A, Saha S, Whitehead DC, Kabanov A. Enhancing Drug Delivery with Supramolecular Amphiphilic Macrocycle Nanoparticles: Selective Targeting of CDK4/6 Inhibitor Palbociclib to Melanoma. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2023:2023.11.21.567974. [PMID: 38045274 PMCID: PMC10690174 DOI: 10.1101/2023.11.21.567974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Preprint 2
17
Alexander-Bryant AA, Hourigan B, Lynn M, Lee JS. Abstract 3098: Nanotherapeutics for combination drug and gene therapy in treating glioblastoma multiforme. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-3098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
8
18
Hazelton A, Samec T, Boulos J, Gilmore S, Alexander-Bryant A. Abstract 304: Peptide-mediated delivery of siRNAs targeting CSNK2A1 decreases migration of ovarian cancer cells in vitro. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
4
19
Eckert T, Zobaer MS, Boulos J, Alexander-Bryant A, Baker TG, Rivers C, Das A, Vandergrift WA, Martinez J, Zukas A, Lindhorst SM, Patel S, Strickland B, Rowland NC. Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy. Cancers (Basel) 2025;17:462. [PMID: 39941829 PMCID: PMC11816167 DOI: 10.3390/cancers17030462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2024] [Revised: 01/21/2025] [Accepted: 01/26/2025] [Indexed: 02/16/2025]  Open
Review 1
20
Pitz M, Nukovic A, Elpers M, Wilde S, Alexander-Bryant A. Abstract 299: Self-assembling peptide hydrogel for delivery and conversion of temozolomide in glioblastoma treatment. Cancer Res 2021. [DOI: 10.1158/1538-7445.am2021-299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
4
21
Attia MF, Ogunnaike EA, Pitz M, Elbaz NM, Panda DK, Alexander-Bryant A, Saha S, Whitehead DC, Kabanov A. Enhancing drug delivery with supramolecular amphiphilic macrocycle nanoparticles: selective targeting of CDK4/6 inhibitor palbociclib to melanoma. Biomater Sci 2024;12:725-737. [PMID: 38099834 PMCID: PMC10872447 DOI: 10.1039/d3bm01888a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2023]
research-article 1
22
Samec T, Boulos J, Gilmore S, Alexander-Bryant A. Abstract 2868: A novel fusogenic peptide for delivery of bioactive siRNAs targeting CSNK2A1 in ovarian cancer cells in vitro. Cancer Res 2020. [DOI: 10.1158/1538-7445.am2020-2868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
5
23
Pitz M, Elpers M, Nukovic A, Wilde S, Gregory AJ, Alexander-Bryant A. De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells. Biomedicines 2022;10:biomedicines10092164. [PMID: 36140265 PMCID: PMC9495814 DOI: 10.3390/biomedicines10092164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2022] [Revised: 08/11/2022] [Accepted: 08/22/2022] [Indexed: 11/16/2022]  Open
3
Please SIGN IN to browse more articles.
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Open (5)